|
1. Indications And Usage Fluoxetine Tablets Are Indicated For The Treatment Of: Major Depressive Disorder (Mdd). The Efficacy Of Fluoxetine Tablets In Mdd Was Established In One 5-Week Trial, Three 6-Week Trials, And One Maintenance Study In Adults. The Efficacy Of Fluoxetine Tablets Was Also Established In Two 8- To 9-Week Trials In Pediatric Patients 8 To 18 Years Of Age [See Clinical Studies (14.1)]. Obsessions And Compulsions In Patients With Obsessive Compulsive Disorder (Ocd). The Efficacy Of Fluoxetine Tablets In Ocd Was Demonstrated In Two 13-Week Trials In Adults And One 13-Week Trial In Pediatric Patients 7 To 17 Years Of Age [See Clinical Studies (14.2)]. Binge-Eating And Vomiting Behaviors In Patients With Moderate To Severe Bulimia Nervosa. The Efficacy Of Fluoxetine Tablets In Bulimia Nervosa Was Demonstrated In Two 8-Week Trials And One 16-Week Trial In Adults [See Clinical Studies (14.3)]. Panic Disorder, With Or Without Agoraphobia. The Efficacy Of Fluoxetine Tablets In Panic Disorder Was Demonstrated In Two 12-Week Trials In Adults [See Clinical Studies (14.4)]. Fluoxetine Is A Selective Serotonin Reuptake Inhibitor (Ssri) Indicated For The Treatment Of: Major Depressive Disorder (Mdd) (1) Adults: Efficacy Was Established In One 5-Week Trial, Three 6-Week Trials, And One Maintenance Study (14.1) Pediatrics: Efficacy Was Established In Two 8- To 9-Week Trials Of Patients 8 To 18 Years Of Age (14.1) Obsessive Compulsive Disorder (Ocd) (1) Adults: Efficacy Was Established In Two 13-Week Trials (14.2) Pediatrics: Efficacy Was Established In One 13-Week Trial In Patients 7 To 17 Years Of Age (14.2) Bulimia Nervosa (1) Adults: Efficacy Was Established In Two 8-Week Trials And One 16-Week Trial (14.3) Panic Disorder, With Or Without Agoraphobia (1) Adults: Efficacy Was Established In Two 12-Week Trials (14.4)
|